3-hydroxyflavone has been researched along with diosmin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ash, K; Grohmann, K; Manthey, CL; Manthey, JA; Montanari, A | 1 |
| Ahn, S; Jung, H; Jung, Y; Lee, YH; Lim, Y; Shin, SY; Yong, Y | 1 |
| Boulkour, S; Fillastre, JP; Lahouel, M; Segueni, N | 1 |
| Aslan, H; Başoğlu, MS; Bingölballı, AG; Eren, E; Katılmış, H; Oztürkcan, S | 1 |
| Demidova, aK; Krivosheeva, NV; Rychkova, IV; Zubarev, AR | 1 |
| Álvarez-Mon, M; Monserrat, J; Villaescusa, L; Zaragozá, C; Zaragozá, F | 1 |
6 other study(ies) available for 3-hydroxyflavone and diosmin
| Article | Year |
|---|---|
Polymethoxylated flavones derived from citrus suppress tumor necrosis factor-alpha expression by human monocytes.
Topics: Citrus; Cyclic AMP; Flavonoids; Humans; In Vitro Techniques; Lipopolysaccharides; Monocytes; Phosphodiesterase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha | 1999 |
Plant-derived flavones as inhibitors of aurora B kinase and their quantitative structure-activity relationships.
Topics: Apoptosis; Aurora Kinase A; Aurora Kinase B; Aurora Kinase C; Binding Sites; Chromones; Eriocaulaceae; Flavones; G2 Phase Cell Cycle Checkpoints; HCT116 Cells; Humans; M Phase Cell Cycle Checkpoints; Microscopy, Fluorescence; Molecular Docking Simulation; Phosphorylation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Quantitative Structure-Activity Relationship | 2015 |
[The flavonoids effect against vinblastine, cyclophosphamide and paracetamol toxicity by inhibition of lipid-peroxydation and increasing liver glutathione concentration].
Topics: Acetaminophen; Animals; Cyclophosphamide; Diosmin; Female; Flavonols; Glutathione; Hepatocytes; Kinetics; Lipid Peroxidation; Liver; Malondialdehyde; Models, Animal; Quercetin; Rats; Rats, Wistar; Time Factors; Vinblastine | 2004 |
Prevention of cisplatin ototoxicity: Efficacy of micronized flavonoid fraction in a guinea pig model.
Topics: Animals; Antineoplastic Agents; Cisplatin; Cochlea; Diosmin; Disease Models, Animal; Ear Diseases; Female; Flavonoids; Guinea Pigs; Otoacoustic Emissions, Spontaneous | 2012 |
[Ultrasound elastography in assessing efficacy of treatment for lower limb varicose veins with a phlebotrophic drug containing a micronized purified flavonoid fraction].
Topics: Biological Availability; Diosmin; Drug Combinations; Drug Monitoring; Elasticity; Elasticity Imaging Techniques; Feasibility Studies; Female; Flavonoids; Hesperidin; Humans; Lower Extremity; Male; Middle Aged; Phlebitis; Saphenous Vein; Severity of Illness Index; Treatment Outcome; Varicose Veins; Venous Insufficiency | 2014 |
Potential Therapeutic Anti-Inflammatory and Immunomodulatory Effects of Dihydroflavones, Flavones, and Flavonols.
Topics: Anti-Inflammatory Agents; Diosmin; Dose-Response Relationship, Immunologic; Female; Flavanones; Flavones; Flavonoids; Flavonols; Healthy Volunteers; Humans; Interleukin-1beta; Interleukin-6; Interleukin-8; Leukocytes, Mononuclear; Lipopolysaccharides; Male; Primary Cell Culture; Quercetin; Rutin; Tumor Necrosis Factor-alpha; Young Adult | 2020 |